BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Exp Med. Mar 20, 2026; 16(1): 111034
Published online Mar 20, 2026. doi: 10.5493/wjem.v16.i1.111034
Figure 2
Figure 2 Flow cytometric immunophenotyping of a case of B-acute lymphoblastic leukemia with CD10+, CD19+, HLA-DR+, dim CD34, and dim CD20 blasts. Gated abnormal population (in red) showing immunopositivity for CD19, HLADR, CD34, CD7, CD5, CD3, compatible with precursor B-ALL with aberrant expression of CD7. A: CD19; B: HLADR; C: CD34; D: CD7; E: CD5; F: CD3. CD3 is negative.


Write to the Help Desk